114 related articles for article (PubMed ID: 35192400)
1. TSPYL2 reduced gefitinib resistance and DNA damage repair via suppressing SIRT1-mediated FOXO3 deacetylation.
Liu Z; Li C; Yu C; Chen Z; Zhao C; Ye L
Future Med Chem; 2022 Mar; 14(6):407-419. PubMed ID: 35192400
[No Abstract] [Full Text] [Related]
2. A tumor-suppressing role of TSPYL2 in thyroid cancer: Through interacting with SIRT1 and repressing SIRT1/AKT pathway.
Zhang X; Wu X; Yao W; Wang YH
Exp Cell Res; 2023 Nov; 432(1):113777. PubMed ID: 37696385
[TBL] [Abstract][Full Text] [Related]
3. TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.
Magni M; Buscemi G; Maita L; Peng L; Chan SY; Montecucco A; Delia D; Zannini L
Cell Death Differ; 2019 May; 26(5):918-931. PubMed ID: 30050056
[TBL] [Abstract][Full Text] [Related]
4. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of icariin-mediated SIRT1/FOXO3 signaling pathway on intestinal ischemia/reperfusion-induced acute lung injury.
Zhang F; Li ZL; Xu XM; Hu Y; Yao JH; Xu W; Jing HR; Wang S; Ning SL; Tian XF
Mol Med Rep; 2015 Jan; 11(1):269-76. PubMed ID: 25323330
[TBL] [Abstract][Full Text] [Related]
6. NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.
Huang TY; Chang TC; Chin YT; Pan YS; Chang WJ; Liu FC; Hastuti ED; Chiu SJ; Wang SH; Changou CA; Li ZL; Chen YR; Chu HR; Shih YJ; Cheng RH; Wu A; Lin HY; Wang K; Whang-Peng J; Mousa SA; Davis PJ
Cells; 2020 Aug; 9(8):. PubMed ID: 32756527
[TBL] [Abstract][Full Text] [Related]
7. FOXQ1-mediated SIRT1 upregulation enhances stemness and radio-resistance of colorectal cancer cells and restores intestinal microbiota function by promoting β-catenin nuclear translocation.
Yang M; Liu Q; Dai M; Peng R; Li X; Zuo W; Gou J; Zhou F; Yu S; Liu H; Huang M
J Exp Clin Cancer Res; 2022 Feb; 41(1):70. PubMed ID: 35183223
[TBL] [Abstract][Full Text] [Related]
8. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
Gao Z; Li Z; Liu Y; Liu Z
Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
[TBL] [Abstract][Full Text] [Related]
9. miR-19a/b-3p promotes inflammation during cerebral ischemia/reperfusion injury via SIRT1/FoxO3/SPHK1 pathway.
Zhou F; Wang YK; Zhang CG; Wu BY
J Neuroinflammation; 2021 May; 18(1):122. PubMed ID: 34051800
[TBL] [Abstract][Full Text] [Related]
10. FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop.
Bing Z; Han J; Zheng Z; Liang N
Life Sci; 2021 Dec; 287():120012. PubMed ID: 34619168
[TBL] [Abstract][Full Text] [Related]
11. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract][Full Text] [Related]
12. Icariin protects against intestinal ischemia-reperfusion injury.
Zhang F; Hu Y; Xu X; Zhai X; Wang G; Ning S; Yao J; Tian X
J Surg Res; 2015 Mar; 194(1):127-38. PubMed ID: 25472572
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 promotes DNA repair activity and deacetylation of Ku70.
Jeong J; Juhn K; Lee H; Kim SH; Min BH; Lee KM; Cho MH; Park GH; Lee KH
Exp Mol Med; 2007 Feb; 39(1):8-13. PubMed ID: 17334224
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.
An Y; Wang B; Wang X; Dong G; Jia J; Yang Q
Cell Death Dis; 2020 Feb; 11(2):115. PubMed ID: 32051395
[TBL] [Abstract][Full Text] [Related]
16. High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway.
Liu L; Yan X; Wu D; Yang Y; Li M; Su Y; Yang W; Shan Z; Gao Y; Jin Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):178. PubMed ID: 30064475
[TBL] [Abstract][Full Text] [Related]
17. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
[TBL] [Abstract][Full Text] [Related]
18. Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling.
Wang FM; Sarmasik A; Hiruma Y; Sun Q; Sammut B; Windle JJ; Roodman GD; Galson DL
Bone; 2013 Mar; 53(1):269-76. PubMed ID: 23262029
[TBL] [Abstract][Full Text] [Related]
19. Carbocysteine counteracts the effects of cigarette smoke on cell growth and on the SIRT1/FoxO3 axis in bronchial epithelial cells.
Pace E; Di Vincenzo S; Ferraro M; Bruno A; Dino P; Bonsignore MR; Battaglia S; Saibene F; Lanata L; Gjomarkaj M
Exp Gerontol; 2016 Aug; 81():119-28. PubMed ID: 27237816
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancer.
Sobolesky PM; Halushka PV; Garrett-Mayer E; Smith MT; Moussa O
PLoS One; 2014; 9(9):e107530. PubMed ID: 25202904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
